EVO Evotec SE
$1.73▼ -2.26%
Healthcare
Other
After hours
$1.72▼ -0.58%
Sep 11, 7:30 PM ET
Volume 41.9K
Avg Volume (10D) 56.0K
Key Metrics & Fundamentals
Market Cap
$614.82M
P/E Ratio
–
Div Yield
–%
52W Range
1.72 - 4.27
% vs 50 MA
-16.08%
% vs 200 MA
-38.44%
RSI-14
32.7
MACD Histogram
+0.0000
Beta (1Y vs SPY)
1.55
Free Cash Flow
-$118.20M
Gross Rev
$143.48M
Gross Profit
-$1.58M
EBITDA
-$91.03M
COGS
$145.06M
Operating Exp
$87.74M
Operating Income
-$89.32M
EBIT
-$89.32M
Pretax Income
-$48.12M
Net Income
-$46.65M
Price & Volume History
Loading chart…
Recent News
Evotec Initiates Phase 1 Trial of Potential Smallpox, Mpox Treatment
MT Newswires · Sep 9, 2026 7:52 AM
Just - Evotec Biologics Advances U.S. Department of War Antibodies Against Orthopoxvirus into Phase 1 Clinical Studies
PR Newswire · Sep 9, 2026 6:00 AM
Evotec, Plectonic Launch Research Collaboration on New T-Cell Approaches for Solid Tumors
MT Newswires · Sep 2, 2026 10:05 AM
Evotec and Plectonic Enter Research Collaboration to Explore New Generation of T-Cell-Engaging Approaches for Solid Tumors
PR Newswire · Sep 2, 2026 6:04 AM
Odyssey Therapeutics (ODTX) Looks Fully Valued As Earnings And Evotec Deal Refocus Attention
Simply Wall St. · Aug 11, 2026 12:19 AM
Evotec and Odyssey collaborate on AI-enabled R&D
Pharmaceutical Technology · Aug 7, 2026 10:10 AM
Evotec, Odyssey Therapeutics Partner to Develop Autoimmune, Inflammatory Disease Treatments
MT Newswires · Aug 6, 2026 8:30 AM
Evotec and Odyssey Therapeutics Enter AI-Enabled R&D Collaboration in Autoimmune and Inflammatory Diseases
PR Newswire · Aug 6, 2026 6:16 AM
Niagen Bioscience, Evotec to Advance Preclinical Development of NB4168
MT Newswires · Aug 3, 2026 1:38 PM
Niagen Bioscience Selects Global Drug Development Pioneer Evotec to Advance Preclinical Development for NB4168
Business Wire · Aug 3, 2026 12:32 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See EVO's money flow as a full page
Social Sentiment
Avg +0.28 · 7 posts
TradePriceTargetEarningsEVO BET
r/wallstreetbets · Nov 5, 2025
The author expresses hope for gains and a 40% price target, indicating a bullish sentiment.
positive
+0.60
TradePriceTargetDiscussionEVO BET
r/wallstreetbets · Nov 5, 2025
The author expresses hope for 'big gains' and a potential 40% upside, indicating a bullish sentiment.
positive
+0.60
NewsDiscussionShort HOG
r/wallstreetbets · Aug 4, 2025
The post criticizes the discontinuation of the EVO engine platform.
negative
-0.70
DiscussionPriceTargetEvotec a undervalued Biotec Stock
r/wallstreetbets · Oct 17, 2024
The post expresses a bullish view on the stock and provides a price target, indicating a positive sentiment.
positive
+0.60
TradeStarted in April 2024, opinions?
r/StockMarket · Oct 17, 2024
The author's direct mention of buying 'EVO' indicates relevance.
positive
+0.30
Page 1 of 2 (7 total)
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.